Elodie Peyric
AuthID: R-00H-NC0
1
TÃTULO: Constitutive single nucleotide polymorphisms (SNP) assessment for predicting tolerability and efficacy of triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-CET) in patients (pts) with liver metastases from colorectal cancer (LM-CRC) (European trial OPTILIV, NCT00852228).
AUTORES: Francis Levi; Abdoulaye Karaboue; Raphael Saffroy; Elodie Peyric; Michel Ducreux; Denis Michel Smith; Mohamed Hebbar; Pasquale F Innominato; Simon Pernot; Carlos Carvalho; Rosine Guimbaud; Focan, CNJ; Mohamed Bouchahda; Rene Adam; Marie Christine Etienne Grimaldi; Gerard A Milano; Antoinette Lemoine;
PUBLICAÇÃO: 2014, FONTE: 50th Annual Meeting of the American-Society-of-Clinical-Oncology in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 32, NÚMERO: 15
AUTORES: Francis Levi; Abdoulaye Karaboue; Raphael Saffroy; Elodie Peyric; Michel Ducreux; Denis Michel Smith; Mohamed Hebbar; Pasquale F Innominato; Simon Pernot; Carlos Carvalho; Rosine Guimbaud; Focan, CNJ; Mohamed Bouchahda; Rene Adam; Marie Christine Etienne Grimaldi; Gerard A Milano; Antoinette Lemoine;
PUBLICAÇÃO: 2014, FONTE: 50th Annual Meeting of the American-Society-of-Clinical-Oncology in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 32, NÚMERO: 15
INDEXADO EM: 
WOS
WOS